(0 items)
Small Medium Large | Print-Friendly Version of this Page  | Email this Page to a Friend
Skip Navigation Links
Press Releases
Hot Topics
White Papers
Contact Public Relations
AABB > Press Room > Press Releases

For Immediate Release
April 15, 2010 
AABB Public Relations Department

 AABB and Fenwal Continue Scholarship Awards Program to Promote Leadership in Blood Banking and Transfusion Medicine 

Submission Deadline is June 1, 2010

Bethesda, Md. – AABB and Fenwal, Inc. are pleased to announce they are continuing the AABB-Fenwal Specialist in Blood Bank and Transfusion Medicine Fellow Scholarship Awards program. Fenwal has partnered with AABB on this effort for nearly 30 years as a means to attract and develop new leaders in blood banking and transfusion medicine.

“AABB-Fenwal scholarships provide educational opportunities to individuals who are new to the blood banking and transfusion medicine community,” said Karen Shoos Lipton, JD, chief executive officer of AABB. “AABB thanks Fenwal for its generous support to ensure continuation of these awards.”

The AABB-Fenwal SBB Scholarship Awards are available to individuals who are enrolled, accepted for enrollment in, or who have recently completed training (within12 months) leading to SBB certification from an AABB-accredited institution. The AABB-Fenwal TMF Scholarship Awards are open to professionals with a Doctor of Medicine or Doctor of Osteopathic Medicine degree who are current fellows in a transfusion medicine program or training program that includes at least one continuous year in transfusion medicine training.

The 2010 Scholarship Awards Program is accepting applications until Tues., June 1, 2010. To learn more about the eligibility and application process, visit AABB’s Web site: www.aabb.org > Professional Development > Awards and Scholarships > AABB-Fenwal Scholarships, or click on this direct link: http://www.aabb.org/Content/Professional_Development/Professional_Development_Awards_and_Scholarships/Fenwal_Scholarships/.

All applications are reviewed by AABB’s Scientific Section Coordinating Committee’s Special Projects group. Typically, two applicants from each scholarship category are selected and recipients are presented with their awards at AABB’s Annual Meeting & CTTXPO during the SSCC business luncheon.

“Fenwal is focused not only on the best blood-collection and transfusion-medicine technologies, but on helping to develop the next generation of leaders in these vitally important fields,” said Ron K. Labrum, president and chief executive officer of Fenwal, Inc. “The professionals who are entrusted to maintain and improve blood supplies and transfusion around the world have an essential and challenging job. Our mission is to help them succeed.”

About AABB

Established in 1947, AABB is an international, not-for-profit association dedicated to the advancement of science and the practice of transfusion medicine and related biological therapies. The association is committed to improving health by developing and delivering standards, accreditation and educational programs and services to optimize patient and donor care and safety. AABB membership consists of approximately 1,800 institutions and 8,000 individuals, including physicians, scientists, administrators, medical technologists, nurses, researchers, blood donor recruiters and public relations personnel. Members are located in all 50 states and 80 countries. For more information, please visit www.aabb.org.

About Fenwal, Inc.

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components. Fenwal is unique in the depth of its experience and commitment to transfusion medicine. The company offers the broadest range of products for the automated and manual collection of blood and blood components. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, single-use container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company’s products and advanced collection and separation technologies are used to help treat patients on six continents. Fenwal, Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.


Home  |  Site Map  | AABB © 2014. All rights reserved. |  Privacy Statement  |  Terms of Use